헬스케어 바이오컨버전스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Healthcare Bioconvergence Market size is expected to reach USD 97.01 Billion in 2034 from USD 45.56 Billion (2025) growing at a CAGR of 8.76% during 2026-2034.

The Global Healthcare Bioconvergence Market represents the integration of biology with engineering, data science, and advanced technologies. This interdisciplinary approach is transforming healthcare by enabling innovations such as bioengineered tissues, smart drug delivery systems, and advanced diagnostics. Growing demand for personalized and efficient healthcare solutions is driving investment in bioconvergence research and development worldwide.

Major drivers include rapid advancements in biotechnology, artificial intelligence, and nanotechnology. Pharmaceutical and medical device companies are collaborating with tech firms to create next-generation healthcare solutions. Increased funding for precision medicine initiatives and regenerative medicine research is also fueling market growth. Academic institutions and startups play a vital role in accelerating innovation in this field.

Looking forward, healthcare bioconvergence is expected to revolutionize treatment approaches and disease management. The integration of digital technologies with biological systems will enhance patient monitoring and therapeutic outcomes. Regulatory support and cross-industry partnerships will be essential for scaling innovations. As healthcare systems shift toward more integrated and technology-driven models, the bioconvergence market is poised for significant expansion in the years ahead.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Drug Discovery
• Nanorobotics for Drug Delivery
• Regenerative Medicine
• Diagnostic and Biological Sensor
• Bioelectronics
• Engineered Living Materials
• Optogenetics
• Precision Medicine

By End User

• Pharmaceutical & Biotechnology Industry
• Contract Research Organization (CRO)
• Others

COMPANIES PROFILED

• Ginkgo Bioworks, Thermo Fisher Scientific Inc, GE Healthcare, Siemens AG, BiomX, Century Therapeutics, Singota Solutions, Galvani Bioelectronics, Bico Group, SetPoint Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nanorobotics for Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Diagnostic and Biological Sensor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bioelectronics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Engineered Living Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Optogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical & Biotechnology Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Contract Research Organization (CRO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE BIOCONVERGENCE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Ginkgo Bioworks
  • 8.2.2 Thermo Fisher Scientific Inc
  • 8.2.3 GE Healthcare
  • 8.2.4 Siemens AG
  • 8.2.5 BiomX
  • 8.2.6 Century Therapeutics
  • 8.2.7 Singota Solutions
  • 8.2.8 Galvani Bioelectronics
  • 8.2.9 Bico Group
  • 8.2.10 SetPoint Medical